Robotic arm brace for arm rehabilitation after spinal cord injury
Tests a wearable robotic arm device in hospital patients with spinal cord injury.
Key facts
- Who runs it
- University of Liverpool
- Where
- United Kingdom2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation
- Status
- Recruiting
- People taking part
- 9 people, planned
- Started
- 1 Sept 2022
- Planned end
- Mar 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Experimental: Device Intervention
- Record updated
- 4 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a spinal cord injury that affects both arms and legs (tetraplegia). They will train one arm with a wearable robotic arm brace for 12 weeks.
- Age
- 18 years and older.
- Sex
- All sexes can join.
- Disease stage
- Spinal cord injury at neck level C5 or C6, ASIA grade C or D. People with injury at C7 or C8 may also join. People need some rough shoulder movement, some feeling in the hand, and some sitting balance. Muscle stiffness (spasticity) must be MAS 1-3/5. They must have little or no everyday use of the arm in the community.
- Biomarker or test result
- A muscle activity test (EMG) must show active finger bending and straightening, and elbow bending and straightening, Grade 1-2.
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age 18+ years
- The levels of C5 C6 Asia C/D would provide individuals with elbow and hand impairment and potentially functional shoulder movements. C7, C8 individuals could also benefit from the hand component of the device
- Some gross shoulder movement at start of the trial to enable changes at the elbow/hand, to have the greatest potential for functional change
- Preservation of hand sensation as base for motor restoration
- Some sitting balance would give the best opportunity for the arm to be released for functional upper limb activity
- EMG (muscle activity) evidence of active finger flexion, extension and elbow flexion extension Grade 1-2
- Minimal or No community functional use of upper limb at start of trial
- Spasticity MAS 1-3/5
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Rehabilitation robotics has the potential to facilitate rehabilitation at home and empower people with spinal injuries to self-manage increasing their independence and improving their quality of life.
Read full original descriptionShow less
The objective of this study is to assess for the first time in the NHS the efficacy of a commercial robotic orthosis for upper limb rehabilitation in patients with spinal cord injury. The device is produced by Myomo (myomo.com) which is an American company. We will be assessing the wearable robotic orthosis also known as robotic exoskeleton in two different neuro-rehabilitation centres: National Spinal injuries Unit in Glasgow (Scotland) and The Robert Jones and Agnus Hunt Orthopaedic Hospital in Oswestry (England). The study will involve nine spinal cord injured tetraplegic inpatients in total.
Patients will follow a twelve-week rehabilitation programme with three to four sessions per week in addition to their usual care and rehabilitation. Each session lasts for approximately 45 minutes. Participants arm function, range of motion, spasticity level will be measured before, half-way and at the end of the programme to assess change in these and other parameters. Training will focus on the dominant arm of the patient and compared to the other arm at every assessment stage.
We shall evaluate therapists' and patients' satisfaction with the commercial device in addition to assessing various clinical measures to evaluate the efficacy of using the robotic orthosis in rehabilitation and recovery of arm function.
The 2 groups in the trial
- Device InterventionTreatment being tested
The intervention group who will be undergoing rehabilitation using the robotic exoskeleton in addition to the assigned traditional rehabilitation programme on their dominant arm only.
Treatment: Experimental: Device Intervention
- ControlNo study treatment, for comparison
the matched control group will be the same subjects undergoing traditional rehabilitation only on their non-dominant arm.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- EXO4UL- Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation of Spinal Cord Injured Patients
- Plain-language title
- Robotic arm brace for arm rehabilitation after spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 4 September 2025